Related Experiment Video
Updated: May 6, 2026

Using Click Chemistry to Measure the Effect of Viral Infection on Host-Cell RNA Synthesis
Published on: August 9, 2013
The nucleoside analog 4'-fluorouridine suppresses the replication of multiple enteroviruses by targeting 3D
Yongkang Chen1, Xiaohong Li2, Fengyang Han3
1Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), Shanghai Institute of Infectious Disease and Biosecurity, School of Basic Medical Sciences and Shanghai Public Health Clinical Center, Fudan University, Shanghai, China.
Abstract:
Human enteroviruses are the major pathogens causing hand-foot-and-mouth disease in infants and young children throughout the world, and infection with enterovirus is also associated with severe complications, such as aseptic meningitis and myocarditis. However, there are no antiviral drugs available to treat enteroviruses infection at present. In this study, we found that 4'-fluorouridine (4'-FlU), a nucleoside analog with low cytotoxicity, exhibited broad-spectrum activity against infections of multiple enteroviruses with EC50 values at low micromolar levels, including coxsackievirus A10 (CV-A10), CV-A16, CV-A6, CV-A7, CV-B3, enterovirus A71 (EV-A71), EV-A89, EV-D68, and echovirus 6. With further investigation, the results indicated that 4'-FlU directly interacted with the RNA-dependent RNA polymerase of enterovirus, the 3D pol, and impaired the polymerase activity of 3D pol, hence inhibiting viral RNA synthesis and significantly suppressing viral replication. Our findings suggest that 4'-FlU could be promisingly developed as a broad-spectrum direct-acting antiviral agent for anti-enteroviruses therapy.
Insights
4'-fluorouridine (4'-FlU) shows broad-spectrum antiviral activity against enteroviruses, inhibiting viral replication by targeting the 3D polymerase. This nucleoside analog offers a promising therapeutic candidate for enterovirus infections lacking current treatments.
Area of Science:
- Virology
- Infectious Diseases
- Drug Discovery
Background:
- Human enteroviruses are significant global pathogens responsible for hand-foot-and-mouth disease and severe complications like meningitis and myocarditis.
- Current therapeutic options for enterovirus infections are limited, highlighting the urgent need for effective antiviral agents.
Purpose of the Study:
- To identify and characterize novel antiviral compounds against a range of human enteroviruses.
- To investigate the mechanism of action of promising antiviral candidates.
Main Methods:
- Screening of nucleoside analogs for antiviral activity against multiple enterovirus strains.
- Determination of EC50 values for effective antiviral concentrations.
- Investigating the interaction of the compound with the enterovirus 3D RNA-dependent RNA polymerase (3Dpol).
Main Results:
- 4 '-fluorouridine (4 '-FlU) demonstrated broad-spectrum antiviral activity against diverse enteroviruses, including coxsackievirus strains and enterovirus A71, with EC50 values in the low micromolar range.
- 4 '-FlU was found to directly inhibit the RNA-dependent RNA polymerase (3Dpol) activity of enteroviruses.
- This inhibition of 3Dpol activity led to suppressed viral RNA synthesis and replication.
Conclusions:
- 4 '-fluorouridine is a potent inhibitor of enterovirus replication through direct targeting of the viral polymerase.
- 4 '-FlU represents a promising direct-acting antiviral agent for the development of novel therapies against enterovirus infections.
More Related Videos
12:20Bacterial Artificial Chromosomes: A Functional Genomics Tool for the Study of Positive-strand RNA Viruses
Published on: December 29, 2015
08:46Regioselective O-Glycosylation of Nucleosides via the Temporary 2',3'-Diol Protection by a Boronic Ester for the Synthesis of Disaccharide Nucleosides
Published on: July 26, 2018
Related Concept Videos
Retrovirus Life Cycles
Viruses with RNA Genomes
Subviral Agents
Inhibitors of Bacterial DNA Synthesis
Inhibitors of Viral Protein Synthesis